CGIX - Cancer Genetics beats by $0.02 beats on revenue April, 16 2019 07:46 AM Cancer Genetics Inc. Cancer Genetics (NASDAQ:CGIX): Q4 GAAP EPS of -$0.14 beats by $0.02.More news on: Cancer Genetics, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...